These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23089529)

  • 21. Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation.
    Gunn J; Kuttila K; Kiviniemi T; Ylitalo A; Biancari F; Juvonen T; Airaksinen KE
    Ann Med; 2014 Aug; 46(5):330-4. PubMed ID: 24813457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple antithrombotic therapy for atrial fibrillation and coronary stents.
    Shmyr D; Van der Merwe V; Yakiwchuk E; Barry A; Kosar L
    Can Fam Physician; 2017 May; 63(5):375-381. PubMed ID: 28500198
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of Baseline Characteristics and Inhospital Outcomes of Patients and Use of Bare Metal Versus Drug-Eluting Stents During Percutaneous Coronary Intervention 2005 to 2015 at a Single Tertiary Hospital.
    Didier R; Gaglia MA; Lipinski MJ; Koifman E; Kiramijyan S; Negi S; Gai J; Torguson R; Pichard AD; Waksman R
    Am J Cardiol; 2017 May; 119(9):1324-1330. PubMed ID: 28258727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.
    Chandrasekhar J; Mastoris I; Baber U; Sartori S; Schoos M; Bansilal S; Dangas G; Mehran R
    Am Heart J; 2015 Dec; 170(6):1234-42. PubMed ID: 26678646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention.
    Gupta T; Paul N; Kolte D; Harikrishnan P; Khera S; Aronow WS; Mujib M; Palaniswamy C; Sule S; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
    J Am Heart Assoc; 2015 Jun; 4(6):e002069. PubMed ID: 26080814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
    Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.
    Caballero L; Ruiz-Nodar JM; Marín F; Roldán V; Hurtado JA; Valencia J; Manzano-Fernandez S; Sogorb F; Valdes M; Lip GY
    Age Ageing; 2013 Jan; 42(1):70-5. PubMed ID: 22983982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apixaban in other situations?
    Prescrire Int; 2012 Sep; 21(130):203. PubMed ID: 23016248
    [No Abstract]   [Full Text] [Related]  

  • 29. Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Kerneis M; Talib U; Nafee T; Daaboul Y; Pahlavani S; Pitliya A; Furqan MM; Datta S; Kazmi HA; Younes A; Gibson CM
    Prog Cardiovasc Dis; 2018; 60(4-5):524-530. PubMed ID: 29397950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
    Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen KJ; Cuisset T; Kirchhof P; Marín F;
    Thromb Haemost; 2010 Jan; 103(1):13-28. PubMed ID: 20062939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The Experience of Use Triple Antithrombotic Therapy in Patients With Acute Coronary Syndrome and Atrial Fibrillation].
    Lozhkina NG; Hasanova MH; Glebchenko EA; Naidena EA; Kozik VA; Kuimov AD
    Kardiologiia; 2017 Apr; 57(4):94-96. PubMed ID: 28762912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention.
    Ruiz-Nodar JM; Marín F; Lip GY
    Rev Esp Cardiol (Engl Ed); 2013 Jan; 66(1):12-6. PubMed ID: 23098580
    [No Abstract]   [Full Text] [Related]  

  • 33. The Outcome of Percutaneous Coronary Intervention for Significant Atherosclerotic Lesions in Segment Proximal to Myocardial Bridge at Left Anterior Descending Coronary Artery.
    Hao Z; Xinwei J; Ahmed Z; Huanjun P; Zhanqi W; Yanfei W; Chunhong C; Chan Z; Liqiang F
    Int Heart J; 2018 May; 59(3):467-473. PubMed ID: 29681571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role.
    Alexopoulos D; Vlachakis P; Lekakis J
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):319-324. PubMed ID: 28643219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice.
    Boriani G; Lane DA; Windecker S; Huber K; Kirchhof P; Lip GY
    Europace; 2015 Sep; 17(9):1319-22. PubMed ID: 25678602
    [No Abstract]   [Full Text] [Related]  

  • 36. Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting.
    Wrigley BJ; Tapp LD; Shantsila E; Lip GY
    Pol Arch Med Wewn; 2010 Jul; 120(7-8):290-3. PubMed ID: 20693960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Mikkelsson J; Pietilä M; Lalmand J; Rivero-Crespo F; Pentikäinen M; Tedjokusumo P; Karjalainen PP
    Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radial artery pseudoaneurysms: a complication of transradial coronary procedures in patients on chronic antithrombotic therapy (rivaroxaban, VKA).
    Januś B; Nawrot I; Zarębiński M; Nazarewski S; Rowiński O
    Kardiol Pol; 2016; 74(10):1191. PubMed ID: 27748498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.